DHCR24 (3-β-hydroxysteroid-Δ-24-reductase), also known as seladin-1 (selective Alzheimer’s disease indicator-1), was initially identified as being expressed at lower levels in the affected as compared to unaffected brain regions in AD patients [3, 4]. This evidence concerns the gene DHCR24 and early-onset autosomal dominant Alzheimer disease.